174 related articles for article (PubMed ID: 12814470)
1. Smallpox and live-virus vaccination in transplant recipients.
Fishman JA
Am J Transplant; 2003 Jul; 3(7):786-93. PubMed ID: 12814470
[TBL] [Abstract][Full Text] [Related]
2. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
Wharton M; Strikas RA; Harpaz R; Rotz LD; Schwartz B; Casey CG; Pearson ML; Anderson LJ; ;
MMWR Recomm Rep; 2003 Apr; 52(RR-7):1-16. PubMed ID: 12710832
[TBL] [Abstract][Full Text] [Related]
3. Smallpox vaccination and adverse reactions. Guidance for clinicians.
Cono J; Casey CG; Bell DM;
MMWR Recomm Rep; 2003 Feb; 52(RR-4):1-28. PubMed ID: 12617510
[TBL] [Abstract][Full Text] [Related]
4. Clinical guidance for smallpox vaccine use in a postevent vaccination program.
Petersen BW; Damon IK; Pertowski CA; Meaney-Delman D; Guarnizo JT; Beigi RH; Edwards KM; Fisher MC; Frey SE; Lynfield R; Willoughby RE
MMWR Recomm Rep; 2015 Feb; 64(RR-02):1-26. PubMed ID: 25695372
[TBL] [Abstract][Full Text] [Related]
5. Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy.
Wittek R
Int J Infect Dis; 2006 May; 10(3):193-201. PubMed ID: 16564720
[TBL] [Abstract][Full Text] [Related]
6. The new ACAM2000 vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks.
Handley L; Buller RM; Frey SE; Bellone C; Parker S
Expert Rev Vaccines; 2009 Jul; 8(7):841-50. PubMed ID: 19538111
[TBL] [Abstract][Full Text] [Related]
7. Smallpox vaccines for biodefense: need and feasibility.
Artenstein AW; Grabenstein JD
Expert Rev Vaccines; 2008 Oct; 7(8):1225-37. PubMed ID: 18844596
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy discovered after smallpox vaccination: Is vaccinia immune globulin appropriate?
Napolitano PG; Ryan MA; Grabenstein JD
Am J Obstet Gynecol; 2004 Dec; 191(6):1863-7. PubMed ID: 15592266
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis and potential antiviral therapy of complications of smallpox vaccination.
Bray M
Antiviral Res; 2003 Apr; 58(2):101-14. PubMed ID: 12742570
[TBL] [Abstract][Full Text] [Related]
10. Smallpox: a review of clinical disease and vaccination.
Lofquist JM; Weimert NA; Hayney MS
Am J Health Syst Pharm; 2003 Apr; 60(8):749-56; quiz 757-8. PubMed ID: 12749161
[TBL] [Abstract][Full Text] [Related]
11. Bioterrorism. Smallpox vaccinations: how much protection remains?
Cohen J
Science; 2001 Nov; 294(5544):985. PubMed ID: 11691969
[No Abstract] [Full Text] [Related]
12. Separate worlds set to collide: smallpox, vaccinia virus vaccination, and human immunodeficiency virus and acquired immunodeficiency syndrome.
Amorosa VK; Isaacs SN
Clin Infect Dis; 2003 Aug; 37(3):426-32. PubMed ID: 12884168
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of modified vaccinia Ankara as a smallpox vaccine in people with atopic dermatitis.
von Sonnenburg F; Perona P; Darsow U; Ring J; von Krempelhuber A; Vollmar J; Roesch S; Baedeker N; Kollaritsch H; Chaplin P
Vaccine; 2014 Sep; 32(43):5696-702. PubMed ID: 25149431
[TBL] [Abstract][Full Text] [Related]
14. Selection of Vaccinia Virus-Neutralizing Antibody from a Phage-Display Human-Antibody Library.
Shin YW; Chang KH; Hong GW; Yeo SG; Jee Y; Kim JH; Oh MD; Cho DH; Kim SH
J Microbiol Biotechnol; 2019 Apr; 29(4):651-657. PubMed ID: 30856707
[TBL] [Abstract][Full Text] [Related]
15. Smallpox vaccination and patients with human immunodeficiency virus infection or acquired immunodeficiency syndrome.
Bartlett JG
Clin Infect Dis; 2003 Feb; 36(4):468-71. PubMed ID: 12567305
[TBL] [Abstract][Full Text] [Related]
16. Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox.
Pittman PR; Hahn M; Lee HS; Koca C; Samy N; Schmidt D; Hornung J; Weidenthaler H; Heery CR; Meyer TPH; Silbernagl G; Maclennan J; Chaplin P
N Engl J Med; 2019 Nov; 381(20):1897-1908. PubMed ID: 31722150
[TBL] [Abstract][Full Text] [Related]
17. Humoral Immunity to Primary Smallpox Vaccination: Impact of Childhood versus Adult Immunization on Vaccinia Vector Vaccine Development in Military Populations.
Slike BM; Creegan M; Marovich M; Ngauy V
PLoS One; 2017; 12(1):e0169247. PubMed ID: 28046039
[TBL] [Abstract][Full Text] [Related]
18. Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects.
Greenberg RN; Overton ET; Haas DW; Frank I; Goldman M; von Krempelhuber A; Virgin G; Bädeker N; Vollmar J; Chaplin P
J Infect Dis; 2013 Mar; 207(5):749-58. PubMed ID: 23225902
[TBL] [Abstract][Full Text] [Related]
19. Absence of detectable viremia in plasma and peripheral blood mononuclear cells from smallpox vaccinees: implications for blood safety.
Srinivasan K; Akolkar PN; Taffs RE; Hewlett IK
Transfusion; 2006 Sep; 46(9):1589-92. PubMed ID: 16965588
[TBL] [Abstract][Full Text] [Related]
20. IMVAMUNE, an attenuated modified vaccinia Ankara virus vaccine for smallpox infection.
Jones T
Curr Opin Mol Ther; 2008 Aug; 10(4):407-17. PubMed ID: 18683106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]